The Pirbright Institute

Pirbright and GALVmed partner to develop safer Rift Valley fever vaccine The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufact

🆕 Partnership to tackle Rift Valley fever (RVF) 🦟🐄

The Pirbright Institute, through the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), has joined forces with GALVmed to develop and deploy a safer and more effective RVF vaccine for use in LMICs. ⬇️

Study highlights factors driving Crimean-Congo haemorrhagic fever in livestock A study has revealed crucial insights into the transmission patterns and risk factors of

🆕 Study reveals insights into the transmission patterns and risk factors of Crimean-Congo haemorrhagic fever virus (CCHFV) in sheep.

CCHF is a severe tick-borne disease with a high mortality rate in humans and is a priority emerging disease by the World Health Organization (WHO) ⬇️

New partnership to advance RNA vaccines for livestock The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM), based at The Pi

💉 As US RNA vaccine funding is cut, the UK is investing.

A new collaboration between CVIM at Pirbright and CPI will accelerate the development of RNA vaccines for livestock, with broader benefits for human health, through a One Health approach. ⬇️

Trustee Election 2025 – Vote now - Royal Entomological Society Fellows and Members can vote for new Trustees Online voting is open to all members and fellows between 22 July and 26 August 2025.  Voting closes 11.59pm BST on 26 August 2025 View the candidates:…

🪲 Have your say!

Vote for new Trustees at the RES ▶️ buff.ly/VyY6nOE

@allanwatt.bsky.social @ukceh.bsky.social @uniexecec.bsky.social @britishecolsoc.bsky.social @liamcrowley.bsky.social @robin-hutchinson.bsky.social @pirbrightinst.bsky.social @forestresearchuk.bsky.social @nhm-london.bsky.social

New study brings vaccine hopes for deadly Nipah virus Scientists at The Pirbright Institute have taken a major step forward in tackling one of the world’s most dangerous viruses, the

🆕 Study evaluates three vaccine candidates for one of the world’s most dangerous viruses, the Nipah virus.

An international team of scientists led by The Pirbright Institute achieves a breakthrough in controlling a deadly virus with pandemic potential ⬇️

#Zoonoses #Zoonotic #OneHealth

Pirbright signs Concordat for the Environmental Sustainability of Research and Innovation Practice The Pirbright Institute has signed the Concordat for the Environmental Sustainability of Research and Innovation Practice.

🔬🌎 We're proud to have signed the signed the Concordat for the Environmental Sustainability of Research and Innovation Practice.

The concordat encourages coordinated efforts across the sector to reduce environmental impacts of research and embed sustainability into research culture and practice. ⬇️

Pirbright promotes pipeline for talented researchers Three awards which promote talented scientists who pursue leading-edge research have been announced by The Pirbright Institute.

🎊Congratulations to three talented researchers who have received prestigious awards recognising and supporting outstanding talent.

Fellowships have been awarded to Dr Jamie Kelly and Dr Miguel Hernandez-Gonzalez and Dr Taissa Ricciardi-Jorge receives a Strategic Career Development Award (SCDA) ⬇️

Centralised Immunogen Strategy for PRRSV Protection Scientists at The Pirbright Institute have successfully developed a novel modified live vaccine candidate for

🆕 Research offers hope for tackling one of the pig industry’s most costly diseases, porcine reproductive and respiratory syndrome.

Pirbright scientists have successfully developed a novel modified live vaccine candidate using a centralised immunogen approach. ⬇️

www.pirbright.ac.uk/news/central...

Sign up to The Pirbright Institute newsletter Get the latest news, events, and opportunities.

Want to stay up to date with all the latest news and opportunities from us?

📥 Sign up to our newsletter and get updates straight to your inbox ⬇️

Leading Pirbright scientist wins Diversity and Inclusion Award A senior leader who has worked to embed diversity and inclusion across The Pirbright Institute has been recognised with a national award.

🏆 Congratulations to Professor John Hammond, our Director of Research, who has received the @britsocimm.bsky.social Diversity and Inclusion Award 2025.

Read the story ⬇️

CRISPR chicken cell study boosts potential for vaccine development Scientists at The Pirbright Institute have created gene-edited chicken cells that produce significantly higher yields of

Scientists at Pirbright have created gene-edited chicken cells that produce significantly higher yields of influenza A virus and Newcastle disease virus (NDV).

💉 These newly developed cell lines could help revolutionise vaccine production ⬇️

ILESLA-Pirbright Studentship

🔬 PhD studentship: We have an ILESLA–Pirbright studentship for an applicant with interests in virology, immunology and the use of transformative technologies for the diagnosis, study and prevention of viral diseases and immune responses.

Deadline: 11 July 2025 ⬇️

iles.web.ox.ac.uk/ilesla-pirbr...

Darkened image of young pink pigs stood on straw. The image sits behind a pink hexagon containing white text that reads "postdoctoral scientist; research the transmission of and immunity to influenza viruses; location woking; salary range £38,500 to £40,000; closing date 24 june 2025". In the bottom right of the image is the pirbright institute logo.

JOB: Join a pioneering One Health research programme tackling global public health threats like influenza and coronaviruses.

Our Mucosal Immunology group seeks a Postdoctoral Scientist. Apply now ➡️ www.pirbright.ac.uk/careers-and-...

Diagnostic testing How to request virus diagnostic services from our reference laboratories.

🔬Did you know The Pirbright Institute offers international diagnostic testing for high-impact livestock diseases?

We test for:
- African swine fever
- Bluetongue
- Foot-and-mouth disease
- Marek's
...and more.

Full information and pricing ⬇️

One wild boar standing in dried long grass looking at the camera

Colourful microscopy image of African swine fever. Orange yellow background with pink circles.

PhD opportunity: Understand how African swine fever virus (ASFV) interacts with the cellular immune response.

This project is based at Pirbright and ‪@royalvetcollege.bsky.social‬ with an industry placement at ‪@boehringerglobal.bsky.social‬ Animal Health.

🔗 www.pirbright.ac.uk/careers-and-...

Launch of the Biorisk Advisor Training course A new training course developed at The Pirbright Institute has been approved by the Royal Society of Biology (RSB) for continuing professional development (CPD) purposes.

Read the story ⬇️

🎉 We're very proud to announce that our new Biorisk Advisor Training course has been approved by the @rsb.org.uk for continuing professional development (CPD) purposes.

This marks a significant milestone for biosafety specialists seeking formal recognition of their skills.

Scientists pioneer ‘early warning’ analysis for foot-and-mouth disease A novel lineage of foot-and-mouth disease virus (FMDV) can have severe socio-economic impacts in Asia.

🆕 Research reconstructs the evolutionary history of an emerging foot-and-mouth-disease lineage in the Middle East, highlighting its potential to spread more widely in the region and beyond.

Full story ⬇️

Darkened image of a mosquito on a white background sits behind a pink hexagon containing white text that reads"postdoctoral scientist; engineer mosquitoes with reduced ability to transmit viruses; location Woking; salary range £38,500 to £40,000; closing date 12 June 2025." In the bottom right of the photo is the pirbright institute logo.

JOB: Our Viral Gene Expression research group is looking for a Postdoctoral Researcher to join a project examining virus-host interactions between arboviruses and their mosquito vector.

Full details and to apply ➡️ www.pirbright.ac.uk/careers-and-...

Pirbright expertise informs economic analysis for foot-and-mouth disease control How much should policymakers invest in controlling animal diseases that spread across national borders, who should pay, and will intervention really work?

How much should we invest in tackling animal diseases that cross borders and who should pay? 🐄🌍

Pirbright’s Dr Georgina Limon-Vega co-authored a new @fao.org handbook offering data-driven answers for FMD and other transboundary threats ⬇️

An announcement poster stating 'We have detected West Nile virus in mosquitoes collected in the UK for the first time', with a mosquito graphic.

🆕 Today, UKHSA and the Animal and Plant Health Agency (APHA) have confirmed the first detection of West Nile virus in mosquitoes collected in the UK.
There is currently no evidence of wider circulation in birds or mosquitoes, and the risk to the public remains very low.
📰🔗 www.gov.uk/government/n...

Single warthog on dried grass

PhD studentship: African swine fever is a highly contagious disease in domestic pigs and wild boar. Over the past 20 years, the disease has spread across the globe.

Investigate how African swine fever virus (ASFV) evades immune responses.

Full details ➡️ www.pirbright.ac.uk/careers-and-...

Pirbright’s openness on animal research rewarded The Pirbright Institute’s commitment to openness on animal research has been rewarded with continued recognition from Understanding Animal Research (UAR).

🏆 We're delighted to have been awarded Leader in Openness status from @animalresearch.bsky.social!

The award recognises the Institute’s commitment to the UAR Concordat on Openness on Animal Research in the UK.

Full story ⬇️

Pirbright in £10m collaboration to fight animal and plant disease The Pirbright Institute has joined a £10m advanced technology surveillance programme to strengthen the UK’s biosecurity and protect animals, plants, people and trade.

🧬 We're proud to join a £10 million UK-wide collaboration to combat animal and plant diseases through advanced genome sequencing.

The Genomics for Animal and Plant Disease Consortium (GAP-DC) uses genomics to enhance UK biosecurity.

Full story ⬇️

Pigs provide insights into coronavirus-induced lung damage Respiratory viruses are a major threat to global health, but why some people experience severe lung damage from infections like SARS-CoV-2 while others have mild symptoms is something that researchers...

Why do some people experience severe lung damage from infections like SARS-CoV-2, while others have mild symptoms?

🐖 A new study led by Pirbright researchers uses pigs to investigate what drives differences in disease severity.

Full story ⬇️

Animal trials underway in quest for African swine fever vaccine A vaccine candidate for African swine fever (ASF) is undergoing tests at The Pirbright Institute.Developed in partnership between the Institute and The Vaccine Group (TVG), the candidate is being clin...

A promising new vaccine candidate for African swine fever (ASF) is now being tested at Pirbright in partnership with The Vaccine Group.

ASF is a contagious and deadly disease of pigs that is prevalent in many countries across Europe, Asia and Africa.

Full story ⬇️

Marta Lopez-Nieto, Ioannis Smyrnias, Nicolas Locker @pirbrightinst.bsky.social and colleagues find that activation of the mitochondrial UPR regulates the dynamic formation of stress granules.
journals.biologists.com/jcs/article/...
#JCSMitoSI

Darkened image of a pig snoozing on straw. The image sits behind a pink hexagon containing white text that reads "postdoctoral scientist; investigate immune responses in livestock species; location woking; salary range £38,500 to £40,00; closing date 8 May 2025." In the bottom right is the pirbright institute logo.

JOB: Our T-Cell biology research group is seeking a Postdoctoral Scientist to investigate immune responses in livestock species, following infection and immunisation.

More details and to apply ➡️ www.pirbright.ac.uk/careers-and-...

The Centre is supported by @ukri.org BBSRC, Gates Foundation and the Foreign Commonwealth Development Office.

Groundbreaking celebrates start of CVIM construction A groundbreaking ceremony has celebrated the first major milestone in the delivery of the Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM).

We've officially broken ground on the new Centre for Veterinary Vaccine Innovation & Manufacturing (CVIM) 🎉

💉 CVIM aims to revolutionise animal health solutions by advancing vaccine development and biomanufacturing capabilities.